Showing 1 - 9 results of 9 for search 'Antonio Gómez Caamaño', query time: 0.04s
Refine Results
-
1
-
2
Management of Localized Muscle-Invasive Bladder Cancer from a Multidisciplinary Perspective: Current Position of the Spanish Oncology Genitourinary (SOGUG) Working Group by Antonio Gómez Caamaño, Ana M. García Vicente, Pablo Maroto, Alfredo Rodríguez Antolín, Julián Sanz, María Almudena Vera González, Miguel Ángel Climent, on behalf of the Spanish Oncology Genitourinary (SOGUG) Multisiciplinary Working Group
Published 2021-12-01
Article -
3
Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study by Almudena Zapatero, Antonio Gómez-Caamaño, María Ángeles Cabeza Rodriguez, Laura Muinelo-Romay, Carmen Martin de Vidales, Alicia Abalo, Patricia Calvo Crespo, Luis Leon Mateos, Carlos Olivier, Lorena Vega Vega Piris
Published 2020-06-01
Article -
4
Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study by Jesús Calleja-Escudero, Víctor Barrondo, Andrés Rodriguez-Alonso, Francisco Gómez-Veiga, Joan Bestard, Antonio Gómez-Caamaño, Anne-Sophie Grandoulier, Maria Pérez-Sampietro, Venancio Chantada-Abal, Raúl Poza de Celis, on behalf of ANAREN Study Group
Published 2024-06-01
Article -
5
Epigenome-wide analysis reveals potential biomarkers for radiation-induced toxicity risk in prostate cancer by Carlos Lopez-Pleguezuelos, Miguel E. Aguado-Barrera, Ana Carballo-Castro, Paula Peleteiro, Patricia Calvo-Crespo, Begoña Taboada-Valladares, Ramón Lobato-Busto, Olivia Fuentes-Ríos, Javier Galego-Carro, Carla Coedo-Costa, Antonio Gómez-Caamaño, Ana Vega
Published 2025-03-01
Article -
6
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer by Nuradh Joseph, Nuradh Joseph, Alessandro Cicchetti, Alan McWilliam, Adam Webb, Petra Seibold, Claudio Fiorino, Cesare Cozzarini, Liv Veldeman, Liv Veldeman, Renée Bultijnck, Renée Bultijnck, Valérie Fonteyne, Valérie Fonteyne, Christopher J. Talbot, Paul R. Symonds, Kerstie Johnson, Tim Rattay, Maarten Lambrecht, Karin Haustermans, Gert De Meerleer, Rebecca M. Elliott, Elena Sperk, Carsten Herskind, Marlon Veldwijk, Barbara Avuzzi, Tommaso Giandini, Riccardo Valdagni, Riccardo Valdagni, Riccardo Valdagni, David Azria, Marie-Pierre Farcy Jacquet, Marie Charissoux, Ana Vega, Ana Vega, Ana Vega, Miguel E. Aguado-Barrera, Miguel E. Aguado-Barrera, Antonio Gómez-Caamaño, Antonio Gómez-Caamaño, Pierfrancesco Franco, Elisabetta Garibaldi, Giuseppe Girelli, Cinzia Iotti, Vittotorio Vavassori, Jenny Chang-Claude, Jenny Chang-Claude, Catharine M. L. West, Tiziana Rancati, Ananya Choudhury
Published 2022-10-01
Article -
7
Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer by Urbano Anido-Herranz, Urbano Anido-Herranz, Ovidio Fernandez-Calvo, Juan Ruiz-Bañobre, Juan Ruiz-Bañobre, Juan Ruiz-Bañobre, Sara Martinez-Breijo, Natalia Fernandez-Nuñez, Zulema Nogareda-Seoane, Miguel Garrido-Pumar, Javier Casas-Nebra, Gloria Muñiz-Garcia, Paula Portela-Pereira, Antonio Gomez-Caamaño, Daniel Adolfo Perez-Fentes, Lucia Santome-Couto, Martín Lázaro, Aurea Molina-Diaz, Ana Medina-Colmenero, Sergio Vazquez-Estevez
Published 2024-05-01
Article -
8
Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer by Sarah L. Kerns, Leila Dorling, Laura Fachal, Søren Bentzen, Paul D.P. Pharoah, Daniel R. Barnes, Antonio Gómez-Caamaño, Ana M. Carballo, David P. Dearnaley, Paula Peleteiro, Sarah L. Gulliford, Emma Hall, Kyriaki Michailidou, Ángel Carracedo, Michael Sia, Richard Stock, Nelson N. Stone, Matthew R. Sydes, Jonathan P. Tyrer, Shahana Ahmed, Matthew Parliament, Harry Ostrer, Barry S. Rosenstein, Ana Vega, Neil G. Burnet, Alison M. Dunning, Gillian C. Barnett, Catharine M.L. West
Published 2016-08-01
Article -
9
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort by Adam J. Webb, Emily Harper, Tim Rattay, Miguel E. Aguado-Barrera, David Azria, Celine Bourgier, Muriel Brengues, Erik Briers, Renée Bultijnck, Jenny Chang-Claude, Ananya Choudhury, Alessandro Cicchetti, Dirk De Ruysscher, Maria Carmen De Santis, Alison M. Dunning, Rebecca M. Elliott, Laura Fachal, Antonio Gómez-Caamaño, Sara Gutiérrez-Enríquez, Kerstie Johnson, Ramón Lobato-Busto, Sarah L. Kerns, Giselle Post, Tiziana Rancati, Victoria Reyes, Barry S. Rosenstein, Petra Seibold, Alejandro Seoane, Paloma Sosa-Fajardo, Elena Sperk, Begoña Taboada-Valladares, Riccardo Valdagni, Ana Vega, Liv Veldeman, Tim Ward, Catharine M. West, R. Paul Symonds, Christopher J. Talbot
Published 2022-10-01
Article